Fidelity Investments’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.7M | Sell |
931,926
-77,201
| -8% | -$4.12M | ﹤0.01% | 1401 |
|
|
2025
Q1 | $40.8M | Buy |
1,009,127
+970,403
| +2,506% | +$39.3M | ﹤0.01% | 1423 |
|
|
2024
Q4 | $1.08M | Buy |
38,724
+8,387
| +28% | +$233K | ﹤0.01% | 2644 |
|
|
2024
Q3 | $870K | Buy |
30,337
+26,691
| +732% | +$766K | ﹤0.01% | 2640 |
|
|
2024
Q2 | $85.5K | Sell |
3,646
-6,834
| -65% | -$160K | ﹤0.01% | 3360 |
|
|
2024
Q1 | $265K | Buy |
10,480
+7,408
| +241% | +$187K | ﹤0.01% | 2933 |
|
|
2023
Q4 | $71.7K | Sell |
3,072
-2,747,276
| -100% | -$64.1M | ﹤0.01% | 3354 |
|
|
2023
Q3 | $139M | Buy |
2,750,348
+162,820
| +6% | +$8.24M | 0.01% | 841 |
|
|
2023
Q2 | $121M | Buy |
2,587,528
+1,446,243
| +127% | +$67.5M | 0.01% | 908 |
|
|
2023
Q1 | $43.7M | Buy |
1,141,285
+1,120,874
| +5,492% | +$42.9M | ﹤0.01% | 1310 |
|
|
2022
Q4 | $1.12M | Sell |
20,411
-18,460
| -47% | -$1.01M | ﹤0.01% | 2510 |
|
|
2022
Q3 | $1.32M | Buy |
38,871
+38,289
| +6,579% | +$1.3M | ﹤0.01% | 2539 |
|
|
2022
Q2 | $5K | Buy |
+582
| New | +$5K | ﹤0.01% | 4294 |
|